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ing cannulation, despite the purse string
attaching the aortic cannula.
In our opinion, central cannulation is
safe in acute aortic dissection repair, re-
gardless of the systematic need for an open
distal anastomosis, and the race to find the
best arterial perfusion site seems useless
since the evidence is right before every-
body’s eyes.
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Reply to the Editor:
We appreciate the comments from Drs
Farhat, Sassard, and Jegaden on our arti-
cle describing our experience with direct
cannulation of dissected ascending aorta.
They add further evidence speaking to
the safety of this technique in specific
subpopulations of patients with this dis-
ease. Their group uses this technique
widely but avoids using it in dissections
with suspected rupture or hematoma.
Their exclusion criteria were similar to
our study. As they describe, we have also
placed purse strings in the aorta to secure
the cannula without incident. This com-
bined experience speaks to the feasibility
of the central cannulation in ascending
aortic dissections, which remains a safe
cannulation option in selected situations
for surgeons dealing with this disease.
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A meta-analysis of minimally
invasive coronary artery bypass
versus percutaneous coronary
intervention with stenting for
isolated left anterior descending
artery disease is indispensable
To the Editor:
We read with great interest a meta-analysis
of randomized trials of off-pump coronary
artery bypass versus percutaneous coronary
intervention (PCI) by Bainbridge and asso-
ciates.1 In response to a meta-analysis by
Boodhwani and colleagues2 of randomized
trials comparing surgical versus percutane-
ous treatment of isolated left anterior de-
scending (LAD) artery disease, we3 con-
ducted a meta-analysis of then-available 5
trials of minimally invasive direct coronary
artery bypass (MIDCAB) versus PCI with
stenting in the form of a letter to the editor.
In the meta-analysis by Boodhwani and
coworkers,2 significant heterogeneity ex-
isted because of the inclusion of both
conventional coronary artery bypass and
MIDCAB in the surgical group and both
PCI with or without stenting in the percu-
taneous group. So far as the meta-analysis
by Bainbridge and associates1 is con-
cerned, although 5 of 6 included trials used
MIDCAB technique in the majority of pa-
tients in the surgical arm, in 1 trial by
Eefting and colleagues4 (the largest trial in
the 6 trials) surgical access to the heart was
achieved via median sternotomy in 67%.
Although the trial by Eefting and cowork-
ers4 included patients with multivessel dis-
ease, the other 5 trials were exclusively of
LAD stenting versus left internal thoracic
artery–to–LAD anastomosis. Furthermore,
a flaw of the systematic review by Bain-
bridge and associates1 was missing a trial
by Kim and colleagues5 published in 2005
despite comprehensive searches up until
May 2006. Therefore, we would like to
advocate a meta-analysis of currently avail-
able 6 homogeneous randomized trials of
MIDCAB versus PCI with stenting for iso-
lated LAD disease, including the trial by
Kim and coworkers5 and 5 trials except for
the trial by Eefting and associates4 in-
cluded in the meta-analysis by Bainbridge
and colleagues.1
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Reply to the Editor:
Takagi and colleagues are correct in sug-
gesting that the trial by Kim and associ-
ates1 is relevant to our meta-analysis of
randomized trials of off-pump coronary ar-
tery bypass/minimally invasive direct cor-
onary artery bypass (OPCAB/MIDCAB)
versus percutaneous coronary intervention
(PCI).2 We remain uncertain why this ran-
domized trial was not identified despite
multiple independent searches performed
by experts. It may be that the trial was not
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